The S&P 500 edged up 0.6% on Monday, March 17, after a report showed retail sales recovered in February but fell short of ...
This therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and significantly reducing costs, thus enhancing accessibility in India and ...
Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced the successful completion ...
HARARE, March 15 (Xinhua) -- The Zimbabwean government said Friday that it will boost health funding to cover a gap left by the reduction of U.S. support.
Informa Connect Medical Division announces landmark Geneva-based conference, convening the world's foremost industry leaders ...
Rentosertib is designed to treat IPF by targeting Traf2- and NCK-interacting kinase (TNIK), a serine/threonine kinase whose activation plays a crucial role in cellular processes that include signal ...
In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, ...
TAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE) -- New-generation Contract Development and Manufacturing Organization (CDMO) ...
Accomplished Technology Executive and Entrepreneur Wensheng Fan Joins DeepRx Inc. PITTSBURGH, PENNSYLVANIA / ACCESS Newswire / March 11, 2025 / DeepRx Inc., a predictive analytics company advancing AI ...
Athletics New Zealand is proud to announce an historic contingent of 12 athletes who will compete at the World Athletics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results